Mirna Maciel d'Auriol-Souza

Dr. Mirna Maciel d'Auriol-Souza

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
LCLarissa Dutra Coelho
Larissa Dutra Coelho
MDMirna Maciel d'Auriol-Souza
Mirna Maciel d'Auriol-Souza
Geovanni Dantas CassaliGeovanni Dantas Cassali
Geovanni Dantas Cassali
RSRaphaela A. Silva
Raphaela A. Silva
MPMaria J. N. Paiva
Maria J. N. Paiva
MOMônica Cristina Oliveira
Mônica Cristina Oliveira
Emetic tartar (ET), was used in the treatment of leishmaniasis but its use was discontinued due to its low therapeutic index. Liposomes have been shown to be a promising strategy for delivery of bioactive substances in the region of interest, in order to reduce and/or eliminate undesirable effects. In the present study, liposomes containing ET were prepared and characterized to evaluate acute toxicity as well as their leishmanicidal action using BALB/c mice with an inoculum of Leishmania (Leishmania) infantum. Liposomes were composed of egg phosphatidylcholine and 3ß-[N-(N′,N′-dimethylaminoethane)-carbamoyl]cholesterol, with an average diameter of 200 nm, zeta potential of +18 mV, and ET encapsulated into liposomes at a concentration near 2 g/L. Healthy mice were treated with ET or liposome containing ET (Lip-ET) in a single dose of 16 mg/kg of Sb3+ intravenously and observed for 14 days. The death of two animals in the ET-treated group and no deaths in the Lip-ET-treated group was observed. Higher hepatic and cardiac toxicity were observed in animals treated with ET when compared to animals treated with Lip-ET, blank liposomes (Blank-Lip) and PBS. The study of antileishmanial efficacy was conducted by intraperitoneal administration of Lip-ET, for ten consecutive days. It was observed by limiting dilution that treatments with liposomal formulations containing ET, as well as Glucantime®, led to a significant reduction in parasitic load in spleen and liver (p < 0.05) when compared to the untreated control group.

26 August 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
LCLarissa Dutra Coelho
Larissa Dutra Coelho
MAMarta Gontijo Aguiar
Marta Gontijo Aguiar
MDMirna Maciel d'Auriol-Souza
Mirna Maciel d'Auriol-Souza
MPMaria Paiva
Maria Paiva
CNClésia Nascentes
Clésia Nascentes
MOMônica Cristina Oliveira
Mônica Cristina Oliveira
Background/Objectives: Visceral leishmaniasis remains a serious public health issue, with current antimonial therapies limited by systemic toxicity. Liposomal drug delivery systems offer a promising strategy to improve therapeutic outcomes. In this context, we previously demonstrated the antileishmanial efficacy of the liposomal formulation containing tartar emetic (Lip-TE) in reducing the parasite load in the spleen and liver of animals experimentally infected with Leishmania (Leishmania) infantum, this being an interesting alternative for the treatment of visceral leishmaniasis. In this study, we aimed to evaluate the physicochemical properties, biodistribution, pharmacokinetics, and cardiotoxicity of Lip-TE. Methods: Both Lip-Blank and Lip-TE exhibited monodisperse size distributions (PDI < 0.3), with Lip-TE having an increased particle size (205.1 ± 4.5 nm) compared to Lip-Blank (137.5 ± 0.8 nm). Both formulations demonstrated a positive zeta potential of about +17.0 mV. Biodistribution and cardiotoxicity studies were performed using female BALB/c mice, approximately 8 to 10 weeks old. Results: A significantly greater splenic, hepatic, and renal accumulation of Lip-TE was observed, particularly at 120 min post-injection, compared to Free TE treatment. The pharmacokinetic profile of the treatment with Lip-TE showed higher systemic exposure (AUC), extended half-life and mean residence time, and reduced clearance compared to Free TE treatment. Echocardiographic analysis revealed that treatment with Free TE significantly reduced the ejection fraction percentage and QRS complex prolongation after 10 days of treatment. These alterations persisted at 30 days, indicating progressive cardiotoxicity. In contrast, Lip-TE treatment preserved cardiac function, revealing the protective effect of the liposomal encapsulation. Conclusions: These findings highlight the potential of the Lip-TE treatment to enhance safety and efficacy.

5 May 2026 in Chemical Research in Toxicology
Verified
Journal Article
Open access
SLSynara C. Lopes
Synara C. Lopes
VMVitória K. Felix Monteiro
Vitória K. Felix Monteiro
PLPaola Caroline L. Leocádio
Paola Caroline L. Leocádio
MRMarcus V. F. Rodrigues
Marcus V. F. Rodrigues
MDMirna Maciel d'Auriol-Souza
Mirna Maciel d'Auriol-Souza
ROReinaldo Oria
Reinaldo Oria
MeHg neurotoxicity is well recognized; however, less is known about its effects on metabolism. Here, we integrated in silico and in vivo approaches to investigate MeHg interactions with apolipoprotein E (ApoE) and their metabolic consequences. Computational analyses revealed that human ApoE2 and ApoE3 isoforms establish stable Hg-S bonds with MeHg, while ApoE4 showed no stable binding, suggesting reduced mercury retention capacity. In addition, we evaluated the impact of MeHg intoxication (20 mg/L in drinking water for 20 days) on the liver and epididymal white fat (EWF) in young ApoE knockout (ko) and wild-type mice. Hg levels in hair, liver, and EWF were measured. We also evaluated body weight gain, plasma triglycerides, total cholesterol, and liver injury by assessing steatosis score, SOD, TBAR, AST, and ALT activities. To evaluate EWF, we analyzed adipocyte diameter, plasma leptin levels, and metabolomics. Hg levels were markedly higher among intoxicated mice. ApoE ko mice had higher Hg concentrations in hair but lower levels in liver and EWF than wild-type controls. Among wild-type mice, MeHg compromised weight gain and increased liver TBAR compared to nonchallenged controls. Among nonintoxicated mice, ApoE deficiency significantly increased triglycerides, cholesterol, and liver transaminases, accompanied by reduced EWF wet weight, SOD activity, and leptin levels. MeHg, together with ApoE deficiency, elevated cholesterol, triglycerides, hepatic transaminases, and TBARS. We found distinct EWF metabolite activity in different scenarios of ApoE deficiency and MeHg intoxication, highlighting increased cardiovascular risk when both challenges occur. Further studies are needed to clarify these mechanisms and identify key nutritional interventions.

4 August 2025 in ACS Omega
Verified
Journal Article
Open access
MDMirna Maciel d'Auriol-Souza
Mirna Maciel d'Auriol-Souza
VAViviani Mendes de Almeida
Viviani Mendes de Almeida
CCClênio Silva Cruz
Clênio Silva Cruz
VRVictor de Melo Rocha
Victor de Melo Rocha
PLPaola Caroline Lacerda Leocárdio
Paola Caroline Lacerda Leocárdio
LALeiliane Coelho André
Leiliane Coelho André
Environmental exposure to low levels of pesticide mixtures through food and domestic settings raises significant public health concerns due to their potential link to metabolic diseases, including obesity, type 2 diabetes, and cancer. As the intestinal microbiota and gastrointestinal tract serve as primary contact points for these contaminants, potentially eliminating residues or suffering direct damage leading to dysbiosis, probiotic interventions have emerged as promising therapeutic strategies for metabolic disorders. This study aimed to evaluate, in mice, the consequences of subchronic exposure to low doses of a mixture of three pesticides: glyphosate (15 mg/kg body weight/day), imidacloprid (5 mg/kg body weight/day), and tebuconazole (4 mg/kg body weight/day). Mice were exposed for 6 weeks. The probiotic subsp. longum strain 51A was employed as a therapeutic strategy for gut microbiota modulation. Exposed animals experienced adverse metabolic and genotoxic effects including increased cholesterol and reduced insulin sensitivity, oxidative stress, and intestinal dysbiosis. 51A reversed these effects, improving metabolism and reducing prediabetes markers. As the first study examining this specific pesticide combination, imidacloprid, tebuconazole, and glyphosate highlight the distinct impact of pesticide mixtures on health, suggesting that intestinal dysbiosis may drive the observed metabolic changes, with microbiota modulation aiding recovery.

15 May 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
SLSynara C. Lopes
Synara C. Lopes
PLPaola Leocadio
Paola Leocadio
GCGabriella C. V. Ciurleo
Gabriella C. V. Ciurleo
GMGabriella Araújo Matos
Gabriella Araújo Matos
MDMirna Maciel d'Auriol-Souza
Mirna Maciel d'Auriol-Souza
ROReinaldo Oria
Reinaldo Oria
Methylmercury (MeHg) intoxication is a global health concern. Although MeHg neurotoxicity is well-recognized, less is known about MeHg's effects on metabolism. In this study, we evaluated MeHg intoxication (20mg/L in drinking water for 20 days) effects on liver and epididymal white fat (EWF) in young ApoE knockout (ko) and wild-type mice. The former is well-known to show spontaneous dyslipidemia. Hg levels in hair, liver, and EWF were measured to assess the degree of MeHg exposure. We also evaluated body weight gain, plasma triglycerides, total cholesterol levels, and liver injury by assessing steatosis score, AST, ALT, SOD, and TBAR levels. To evaluate EWF, we analyzed mean wet weight and adipocyte diameter, plasma leptin levels and metabolomics. Hg levels were markedly higher among intoxicated mice. ApoE ko mice showed higher Hg in the hair but lower levels in the liver and EWF than wild-type controls. Among wild-type mice, MeHg compromised weight gain and increased liver TBAR levels compared to non-challenged controls. Among non-intoxicated mice, ApoE deficiency significantly increased triglyceride, total cholesterol, and liver transaminases with reduced EWF wet weight, hepatic SOD, and plasma leptin levels. MeHg accumulation together with ApoE deficiency elevated total cholesterol, triglycerides, hepatic transaminases, and TBARS. We found distinct EWF metabolite activity in different scenarios of ApoE deficiency and MeHg intoxication, highlighting increased cardiovascular risk especially when both challenges occur. Further studies are required to elucidate the underlying mechanisms involved in these effects and the target nutritional interventions in most need to ameliorate them.